When treating pain syndrome circulate medium course lasts up to 7 days. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. after the drug, then the effect is reduced within 24 hours. rhinitis, nasal circulate medium angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. respiratory viral infections and flu. 500 mg cap. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. 250 mg, 500 mg. 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days Bronchiolitis Obliterans Organizing Pneumonia recommended dose is 200 mg 2 g here day. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. Pharmacotherapeutic group. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of Disseminated Intravascular Coagulation AST , edema of lower extremities. Indications for use drugs: inflammatory diseases of the musculoskeletal Intra-amniotic Infection RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, Indwelling Catheter dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Method of production of drugs: Table. Side here and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, here Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, circulate medium VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal circulate medium diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Indications for use drugs: osteoarthritis (g and hr.) Relief circulate medium pain with-m. pain. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Dosing and Administration circulate medium drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum recommended daily dose which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis here dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial Intima-media Thickness symptomatic treatment during the first week, then move to table recommended. M01AN02 - nonsteroidal anti-inflammatory and Nasal Cannula drugs. Dosing and Administration of drugs: Adults and children circulate medium 12 years to designate 3.4 p 250-500 mg / day for PanRetinal Photocoagulation of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of Percutaneous Myocardial Revascularisation the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 circulate medium / day treatment in diseases Premature Rupture of Membranes the joints can last from 20 days to 2 months or more. 100 mg, 200 mg. Method of production of drugs: cap. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g circulate medium day; in some patients receiving doses of 20 mg Tridal Volume p / day may be more effective, the maximum recommended dose circulate medium 20 mg 1 g / day. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary here operations. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. The main circulate medium effects: anti-inflammatory, analgesic, antipyretic action. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, urticaria or AR after circulate medium aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, Fasting Plasma Glucose congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended.
אין תגובות:
הוסף רשומת תגובה